108 related articles for article (PubMed ID: 22122769)
1. The Role of Aminosalicylates in Crohn's Disease.
Bayless T
Gastroenterol Hepatol (N Y); 2006 Mar; 2(3):159-160. PubMed ID: 28286443
[No Abstract] [Full Text] [Related]
2. Review article: the mode of action of the aminosalicylates in inflammatory bowel disease.
Greenfield SM; Punchard NA; Teare JP; Thompson RP
Aliment Pharmacol Ther; 1993 Aug; 7(4):369-83. PubMed ID: 8105984
[TBL] [Abstract][Full Text] [Related]
3. Self-Assembling Polymers with
Keihankhadiv S; Neugebauer D
Pharmaceuticals (Basel); 2023 Oct; 16(10):. PubMed ID: 37895973
[TBL] [Abstract][Full Text] [Related]
4. Molecular Mechanisms of the Antitumor Effects of Mesalazine and Its Preventive Potential in Colorectal Cancer.
Słoka J; Madej M; Strzalka-Mrozik B
Molecules; 2023 Jun; 28(13):. PubMed ID: 37446747
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Characterization of Linear Copolymers Based on Pharmaceutically Functionalized Monomeric Choline Ionic Liquid for Delivery of
Keihankhadiv S; Neugebauer D
Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986721
[TBL] [Abstract][Full Text] [Related]
6. Current evidence and clinical relevance of drug-microbiota interactions in inflammatory bowel disease.
Becker HEF; Demers K; Derijks LJJ; Jonkers DMAE; Penders J
Front Microbiol; 2023; 14():1107976. PubMed ID: 36910207
[TBL] [Abstract][Full Text] [Related]
7. Emerging Nanotechnologies and Microbiome Engineering for the Treatment of Inflammatory Bowel Disease.
Abed OA; Attlassy Y; Xu J; Han K; Moon JJ
Mol Pharm; 2022 Dec; 19(12):4393-4410. PubMed ID: 35878420
[TBL] [Abstract][Full Text] [Related]
8. Identification of Pharmacological Autophagy Regulators of Active Ulcerative Colitis.
Qiu P; Liu L; Fang J; Zhang M; Wang H; Peng Y; Chen M; Liu J; Wang F; Zhao Q
Front Pharmacol; 2021; 12():769718. PubMed ID: 34925026
[No Abstract] [Full Text] [Related]
9. Efficacy and Safety of Melatonin as an Adjunctive Therapy on Clinical, Biochemical, and Quality of Life in Patients with Ulcerative Colitis.
Shahrokh S; Qobadighadikolaei R; Abbasinazari M; Haghazali M; Asadzadeh Aghdaei H; Abdi S; Balaii H; Khanzadeh-Moghaddam N; Zali MR
Iran J Pharm Res; 2021; 20(2):197-205. PubMed ID: 34567156
[TBL] [Abstract][Full Text] [Related]
10. A Novel PAK1-Notch1 Axis Regulates Crypt Homeostasis in Intestinal Inflammation.
Frick A; Khare V; Jimenez K; Dammann K; Lang M; Krnjic A; Gmainer C; Baumgartner M; Mesteri I; Gasche C
Cell Mol Gastroenterol Hepatol; 2021; 11(3):892-907.e1. PubMed ID: 33189893
[TBL] [Abstract][Full Text] [Related]
11. ILC3 function as a double-edged sword in inflammatory bowel diseases.
Zeng B; Shi S; Ashworth G; Dong C; Liu J; Xing F
Cell Death Dis; 2019 Apr; 10(4):315. PubMed ID: 30962426
[TBL] [Abstract][Full Text] [Related]
12. Mesalamine and azathioprine modulate junctional complexes and restore epithelial barrier function in intestinal inflammation.
Khare V; Krnjic A; Frick A; Gmainer C; Asboth M; Jimenez K; Lang M; Baumgartner M; Evstatiev R; Gasche C
Sci Rep; 2019 Feb; 9(1):2842. PubMed ID: 30809073
[TBL] [Abstract][Full Text] [Related]
13. N-Methylcytisine Ameliorates Dextran-Sulfate-Sodium-Induced Colitis in Mice by Inhibiting the Inflammatory Response.
Jiao YF; Lu M; Zhao YP; Liu N; Niu YT; Niu Y; Zhou R; Yu JQ
Molecules; 2018 Feb; 23(3):. PubMed ID: 29495327
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory Bowel Disease Drugs: A Focus on Autophagy.
Hooper KM; Barlow PG; Stevens C; Henderson P
J Crohns Colitis; 2017 Jan; 11(1):118-127. PubMed ID: 27381462
[TBL] [Abstract][Full Text] [Related]
15. Aminosalicylates.
Campregher C; Gasche C
Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):535-46. PubMed ID: 22122769
[TBL] [Abstract][Full Text] [Related]
16. Controversies with aminosalicylates in inflammatory bowel disease.
Lim WC; Hanauer SB
Rev Gastroenterol Disord; 2004; 4(3):104-17. PubMed ID: 15359211
[TBL] [Abstract][Full Text] [Related]
17. Chemoprevention of colorectal cancer in inflammatory bowel disease.
Subramanian V; Logan RF
Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):593-606. PubMed ID: 22122774
[TBL] [Abstract][Full Text] [Related]
18. Drug insight: aminosalicylates for the treatment of IBD.
Nielsen OH; Munck LK
Nat Clin Pract Gastroenterol Hepatol; 2007 Mar; 4(3):160-70. PubMed ID: 17339853
[TBL] [Abstract][Full Text] [Related]
19. Aminosalicylate therapy in the prevention of dysplasia and colorectal cancer in ulcerative colitis.
Rubin DT; LoSavio A; Yadron N; Huo D; Hanauer SB
Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1346-50. PubMed ID: 17059900
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
